Diabetes

Editor's Choice

  • Background: The Study of Micardis (telmisartan) in Overweight/Obese patients with Type 2 diabetes and Hypertension (SMOOTH) compared hydrochlorothiazide (HCTZ) plus telmisartan or valsartan...
  • A range of risk factors for coronary heart disease (CHD) have been identified and the probability of adverse cardiovascular events over the subsequent 10 years can be predicted using tools such as...

Upcoming events

Cardiovascular Disease Prevention 2009: Seventh Annual Comprehensive Symposium

5th - 7th February 2009

We are pleased to announce the Cardiovascular Disease Prevention 2009 A key strategy for addressing cardiovascular heart...

World Congress of Internal Medicine

20th - 25th March 2010

WCIM 2010 and Physicians Week, will offer a stimulating educational program with many networking opportunities with your peers and a chance to keep...

Medical Guidelines

  • Surgery
    To provide clinical risk profile that the patient, primary physician, nonphysician caregivers, anesthesiologist and surgeon can use in making treatment decisions that influence short- and long-term...
  • Pills
    To review the rationale and clinical evidence for the use of angiotensin converting enzyme inhibitors (ACE-I) in patients with cardiovascular disease. INTENDED USERS: Physicians....